MitchelLake Intelligence

Leadership in real time

Live signals — funding, expansion, leadership change — and what they mean for executive talent, drawn from MitchelLake's signal intelligence and 25 years of search.

Talent Market Index109.3Hot · steady

Oceania EasingAsia RisingEMEA EasingAmericas Rising

Full index →

Latest analysis

GlobalMicroba Life Sciences · capital raising

Leadership change accelerates as product launches fade

Leadership change is 14.5% of this week's signals against 11.3% over the prior four weeks; product launches fell from 20% to 12.4%. Oceania and the Americas carry the shift; EMEA's capital-raising run continues. Electro Optic Systems (leadership change), CATL (product launches) and Entertainment Software Rating Board (leadership change) carry it this week.

GlobalXero · product launch

Job cuts rise against trend, but capital-raising and leadership change accelerate

Capital-raising is 23% of this week's signals against 18.8% over the prior four weeks; product launches fell from 20.5% to 12.6%. EMEA and Asia carry the shift; Oceania's dealmaking run continues. Alliant Energy (capital-raising), Financial Advice Association Australia (FAAA) (leadership change) and Arroyo Energy Investment Partners (capital-raising) carry it this week.

GlobalMicroba Life Sciences · leadership change

Microba Life Sciences leads as 뉴엔AI (NewN AI) and Stride move, with product launches out front

Signal tone stays positive. 90% of polar signals point to hiring. Product launch leads the wire in 3 of four markets (Oceania, EMEA, Americas). Asia is the outlier: geographic expansion, restructuring and capital-raising run 1.4–1.6× their global share there, a consolidation tilt.

GlobalCleanaway Waste Management · ma activity

Cleanaway Waste Management leads as Stride and Sea Limited move, with product launches out front

Signal tone stays positive. 89% of polar signals point to hiring. Product launch leads the wire in 3 of four markets (Oceania, EMEA, Americas). Asia is the outlier: geographic expansion, restructuring and capital-raising run 1.4–1.6× their global share there, a consolidation tilt.

GlobalXero · partnership

Sea Limited leads as Xero and Stride move, with product launches out front

GlobalPearson · restructuring

Pearson leads as Stride and Sea Limited move, with product launches out front

Signal tone stays positive. 89% of polar signals point to hiring. Product launch leads the wire in 3 of four markets (Oceania, EMEA, Americas). Asia is the outlier: geographic expansion, restructuring and capital-raising run 1.4–1.7× their global share there, a consolidation tilt.

GlobalFirmus Technologies · capital raising

Firmus Technologies leads as Sea Limited and Coinkite Inc. move, with product launches out front

GlobalFirmus Technologies · capital raising

Firmus Technologies leads as Sea Limited and DayOne Data Centers Ltd. move, with product launches out front

Signal tone stays positive. 89% of polar signals point to hiring. Product launch leads the wire in 3 of four markets (Oceania, EMEA, Americas). Asia is the outlier: geographic expansion, restructuring and capital-raising run 1.4–1.7× their global share there, a consolidation tilt.

GlobalMetcash · ma activity

Metcash leads as Kutlerri.ai and Okestro Cloud move, with product launches out front

Signal tone stays positive. 89% of polar signals point to hiring. Product launch leads the wire in 3 of four markets (Oceania, EMEA, Americas). Asia is the outlier: geographic expansion, restructuring and capital-raising run 1.4–1.7× their global share there, a consolidation tilt.

On the wire

Shionogi

Asia

ma activityproduct launch

Shionogi acquiring IntraBio, an Austin-based commercial biotech, for $2 billion upfront. The acquisition adds an oral rare disease treatment (Aqneursa) to Shionogi's rare disease portfolio.

curated · 2026-10-05 · context →

Shionogi obtained approval in September 2026 for a booster indication of its JN.1 adapted COVGOZE COVID-19 vaccine. Together with Torii Pharmaceutical, Shionogi secured Japanese approval for VTAMA Cream 0.5% to treat atopic dermatitis in children under 12.

curated · 2026-09-28 · context →